Aarti Pharma Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
No of Months
12
12
12
12
Profit Before Tax
360.00
300.00
260.00
155.00
Adjustment
121.00
94.00
83.00
52.00
Changes In working Capital
-86.00
-121.00
-31.00
-230.00
Cash Flow after changes in Working Capital
396.00
273.00
312.00
-22.00
Cash Flow from Operating Activities
331.00
216.00
250.00
-43.00
Cash Flow from Investing Activities
-413.00
-214.00
-157.00
-138.00
Cash Flow from Financing Activities
65.00
9.00
-163.00
260.00
Net Cash Inflow / Outflow
-16.00
11.00
-71.00
77.00
Opening Cash & Cash Equivalents
23.00
12.00
83.00
5.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
6.00
23.00
12.00
83.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Aarti Pharma
Figures in Cr
standaloned Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
234.24
311.62
-77.00
-24.83%
Adjustment
183.42
12.2
171.00
1403.44%
Changes In working Capital
-113.66
-73.81
-40.00
-53.99%
Cash Flow after changes in Working Capital
304.01
250.01
54.00
21.60%
Cash Flow from Operating Activities
257.26
168.69
89.00
52.50%
Cash Flow from Investing Activities
-425.14
9.59
-434.00
-4533.16%
Cash Flow from Financing Activities
170.58
-234.74
404.00
172.67%
Net Cash Inflow / Outflow
2.7
-56.46
58.00
104.78%
Opening Cash & Cash Equivalents
2.84
238.73
-236.00
-98.81%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
5.54
182.27
-177.00
-96.96%
Cash Flow - Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is -24.02% vs 84.32% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
257.26
338.58
-24.02%






